A retrospective study of efficacy of adalimumab, apremilast, etanercept, secukinumab, and ustekinumab in moderate to severe psoriasis patients
Latest Information Update: 12 Nov 2021
At a glance
- Drugs Adalimumab (Primary) ; Apremilast (Primary) ; Etanercept (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 12 Nov 2021 New trial record